Portal de investigación
Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- González-Gil C.
- Morgades M.
- Lopes T.
- Fuster-Tormo F.
- Barba P.
- Díaz-Beya M.
- Hermosín L.
- Maluquer C.
- González-Campos J.
- Bernal T.
- Arriaga M.S.
- Zamora L.
- Pratcorona M.
- Martino R.
- Larrayoz M.J.
- Artola T.
- Torrent A.
- Vall-Llovera F.
- Tormo M.
- Gil C.
- Novo A.
- Martínez-Sánchez P.
- Ribera J.
- Queipo M.-P.
- González-Martínez T.
- Cabrero M.
- Cladera A.
- Orfao A.
- Ribera J.M.
- Genescà E.
Grupos
Abstract
[No abstract available]
Datos de la publicación
- ISSN/ISSNe:
- 0390-6078, 1592-8721
- Tipo:
- Letter
- Páginas:
- 206-211
- PubMed:
- 39113657
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 2,528 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
HAEMATOLOGICA FERRATA STORTI FOUNDATION
Documentos
- No hay documentos
Filiaciones
Keywords
- b cell lymphoma leukemia 11b; cyclin dependent kinase 6; DNA methyltransferase 3A; F box/WD repeat containing protein 7; lymphoid enhancer factor 1; non receptor protein tyrosine phosphatase 2; Notch1 receptor; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; plant homeodomain like finger protein 6; protein Myb; protein p53; rb transcriptional corepressor 1; ribosomal protein l5; tet methylcytosine dioxygenase 2; transcription factor CTCF; transcription factor Elf 1; tumor marker; unclassified drug; WT1 protein; adolescent; adult; cancer prognosis; cancer risk; chromosome 10; chromosome 19; cohort analysis; female; follow up; gene deletion; gene dosage; gene duplication; gene insertion; human; Letter; male; minimal residual disease; prognostic value; risk assessment; T cell acute lymphoblastic leukemia; trisomy; X chromosome; article; major clinical study
Cita
González C,Morgades M,Lopes T,Fuster F,Montesinos P,Barba P,Díaz M,Hermosín L,Maluquer C,González J,Bernal T,Arriaga MS,Zamora L,Pratcorona M,Martino R,Larrayoz MJ,Artola T,Torrent A,Vall F,Tormo M,Gil C,Novo A,Martínez P,Ribera J,Queipo M-P,González T,Cabrero M,Cladera A,Cervera J,Orfao A,Ribera JM,Genescà E. Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials. Haematologica. 2025. 110(1):p. 206-211. IF:8,200. (1).